Cardiovascular Disease Clinical Trials in Bethesda, Maryland

9 studies are recruiting for cardiovascular disease in Bethesda, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

    Background: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart attacks or stroke. No medications have been effective at reducing this risk in people with lupus. Objective: To test whether a drug (anifrol…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    See if you can join NCT05440422 on ClinicalTrials.gov

  2. Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)

    Background: Studies show that rare genetic variants might lead to diseases. Researchers want to collect blood and tissue samples so they can study them and better understand diseases. Objective: To collect blood and tissue samples for studies to identify underlying causes of disease. Eligibility: P…

    Stage
    Not phased
    Ages
    0 to 100
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Heart, Lung, and Blood Institute (NHLBI)

    See if you can join NCT02543996 on ClinicalTrials.gov

  3. Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

    Background: The adrenal gland makes the hormone aldosterone. This helps regulate blood pressure. An adrenal gland tumor that makes too much aldosterone can cause high blood pressure and low potassium. The cause of these tumors is unknown, but sometimes they are inherited. Objective: To study the ge…

    Stage
    Not phased
    Ages
    7 to 70
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    See if you can join NCT03374215 on ClinicalTrials.gov

  4. Technical Development of Cardiovascular Magnetic Resonance Imaging

    Background: In the U.S., over 6.5 million people have heart failure. Researchers want to develop new testing methods for cardiovascular problems using magnetic resonance imaging (MRI) to improve the clinical diagnosis and management of people with heart failure. Objective: To develop and test new m…

    Stage
    Not phased
    Ages
    18 to 100
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Locations
    2 in total
    Run by
    National Heart, Lung, and Blood Institute (NHLBI)

    See if you can join NCT04927429 on ClinicalTrials.gov

  5. Natural History Study of CADASIL

    Background: CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy) is a genetic disorder. It causes narrowing of the small blood vessels and can lead to strokes and dementia. Researchers want to monitor people with CADASIL over time. Objective: To learn …

    Stage
    Not phased
    Ages
    18 to 100
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Heart, Lung, and Blood Institute (NHLBI)

    See if you can join NCT05072483 on ClinicalTrials.gov

  6. Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults

    Background: Omega-7 fatty acids are found in the oil extracted from certain fish and nuts like macadamia. Palmitoleic acid is one of the most common omega-7 fatty acids. Many studies suggest that this oil is good for heart health. Researchers want to find out more about these potential benefits. Ob…

    Stage
    Phase 2
    Ages
    18 to 99
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Heart, Lung, and Blood Institute (NHLBI)

    See if you can join NCT03372733 on ClinicalTrials.gov

  7. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers

    Background: Heart disease is the leading cause of death, disability, and healthcare expense in the United States. Researchers think a new drug called Fx-5A may be useful to treat different cardiovascular diseases and inflammation. Objective: To understand the safety, tolerability, and effects of Fx…

    Stage
    Phase 1
    Ages
    18 to 99
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Heart, Lung, and Blood Institute (NHLBI)

    See if you can join NCT04216342 on ClinicalTrials.gov

  8. Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention

    Background: - Past studies suggest that the best way to improve heart health in the Black community is through community-based programs. Researchers will partner with DC community leaders. They will collect information about the health and health needs of people in mostly Black churches in DC. They…

    Stage
    Not phased
    Ages
    19 to 85
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Heart, Lung, and Blood Institute (NHLBI)

    See if you can join NCT01927783 on ClinicalTrials.gov

  9. OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

    The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp[a]…

    Stage
    Phase 3
    Ages
    50 to 105
    Site
    Suburban Hospital, Bethesda, Maryland
    Locations
    252 in total
    Run by
    Amgen

    See if you can join NCT07136012 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.